NEW YORK, Feb. 16, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Future UK Microbiology Testing Market Outlook

http://www.reportlinker.com/p0771119/Future-UK-Microbiology-Testing-Market-Outlook.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Highlights

Comprehensive 978-page analysis of the UK microbiology testing market. Major issues pertaining to the UK microbiology laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Current scientific views on the definition, epidemiology, and etiology of major infectious diseases and microorganisms. Ten-year test volume and sales forecasts for nearly 80 microbiology tests performed in UK hospitals, blood banks, public health and commercial laboratories. Instrumentation technologies and feature comparison of leading analyzers. Sales and market shares of leading suppliers. Emerging diagnostic technologies and their potential market applications. Product development opportunities. Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers.

Contains 978 pages and 159 tables

IntroductionWorldwide Market and Technology OverviewA. Major Infectious Disease Tests1. AIDSa. Background0 Structure and Composition0 Classification0 Origin of AIDS0 Animal Lentivirus Systems0 Virus Receptos0 HIV Infections in Humans- Pathogenesis & Pathology: Overview ofHIV Infection Course0 CD4T Lymphocytes and Memory Cells0 Monocytes and Macrophages0 Lymphoid Organs0 Neural Cells0 Viral Coinfections- Clinical Findings0 Plasma Viral Load0 Pediatric AIDS- Neurologic Disease- Opportunistic Infections- Cancer0 Immunity- Virus Isolation- Serology- Detection of Viral NucleicAcid and Antigens0 Infectivity0 Epidemiology- Worldwide Spread of AIDS- United States- Routes of Transmission

b. Diagnostic Tests

0 Laboratory Diagnosis

- Enzyme Immunoassay Interpretation

- Specific, Sensitivity, and Predictive

Value of Enzyme Immunoassays

0 Competition Assays

0 Western Blot Technique

0 Immuno-Fluorescence Assay (IFA)

0 Radioimmunoprecipitation

0 HIV-1/HIV-2 Combination Testing

0 Methods of HIV-Antigen Detection

0 Antigen Assays and Blood Screening

0 Urine Tests

0 Immunopathogenic Mechanism of HIV Infection

0 DNA Probes

- Overview

- Quantitative Polymerase Chain Reaction

- In Situ PCR

- Needed Improvements

0 Viral Load/Drug Resistance Testing

0 Genotype and Phenotype Testing

0 Blood Banking Consideration

c. Vaccines and Drugs

- Antiviral Drugs

- Vaccines Against HIV

0 Transmission of HIV in Blood Products

0 HIV Transmission in Transplant and

Artificial Insemination Recipients

2. Adenovirus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

d. Adeno-Associated Viruses(AAV)

3. Aeromonas

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

4. Anthrax/Bacillus Anthracis

a. Background

b. Diagnostic Testsc. Vaccines and Drugs5. Arbovirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs6. Babesiosisa. Background7. Bacillary Epithelioid Angiomatosis (BEA)And Other Bartonella (Rochalimaea)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs8. Blastocystis Hominisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs9. Brucellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs10. Campylobactera. Backgroundb. Diagnostic Tests0 Identification from Culturec. Vaccines and Drugs11. Candidaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs12. Chagas Diseasea. Background13. Chancroida. Backgroundb. Diagnostic Testsc. Vaccines and Drugs14. Chlamydiaa. Background0 Chlamydia Psittaci

0 Chlamydia Pneumoniae

0 Chlamydia Trachomatis

b. Diagnostic Tests

c. Vaccines and Drugs

15. Clostridium Difficile

a. Background

0 Pediatric Infections

0 Epidemiology

b. Diagnostic Tests

0 Counterimmunoelectrophoresis

0 Fluorescent-Antibody Assays

0 Poloymerase Chain Reactions

c. Drugs and Vaccines

16. Coronaviruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

17. Coxsackieviruses

a. Background

0 Herpangina

0 Hand-foot-and-mouth syndrome

0 Hepidemic Conjuctivitis

0 Pharingitis

0 Epidemic Pleurodynia

0 Myodarditis,Pericarditis

0 Overwhelming Infection of the Newborn

0 Acute Aseptic Meningitis

0 Undifferentiated Febrile Illness

0 Fever with upper respiratory infection

0 Encephalitis

0 Asymptomatic Infection

b. Diagnostic Tests

c. Vaccines and Drugs

18. Creutzfeldt-Jakob's Disease

a. Background

0 Blood Transmission

b. Diagnostic Tests

0 Major Commercial and Academic Players

- Bayer

- Disease Sciences/Bio Tec Global- Imperial College of Medicine- Ortho-Clinical Diagnostics- Pall- ProMetic Life Sciences- Proteome Sciences/Idexx- Q-One Biotech- Serono- U.S. Agricultural Research Servicec. Vaccines19. Cryptosporidium Parvuma. Backgroundb. Diagnostic Tests0 Histologic0 Laboratory Parasitology0 Serodiagnosisc. Vaccines and Drugs20. Cyclospora Cayetanensisa. Background0 Asymptomatic Infection0 Diarrhea in Immunocompetent Persons0 Diarrhea in Immunocompromisedersonsb. Diagnostic Testsc. Vaccines and Drugs21. Cytomegalovirusa. Background0 Chorioretinitis0 Gastrointestinal0 Central Nervous System Diseaseb. Diagnostic Testsc. Vaccines and Drugs22. Ebola Virusa. Background0 Epidemiology0 Hemorrhagic Feverb. Diagnostic Testsc. Vaccines and Drugs23. E. Colia. Background

0 Role of Escherichia Coli in

Causing Diarrhea

0 EPEC

0 ETEC

0 EIEC

0 EHEC

b. Diagnostic Tests

c. Vaccines and Drugs

24. EchoVirus

a. Background

0 Acute Aseptic Miningitisis

0 Encephalitis

0 Exanthems

0 Respiratory Disease

0 Myope;ricarditis

0 Neonatal Infections

b. Diagnostic Tests

c. Vaccines and Drugs

25. Encephalitis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

26. Enteroviruses

a. Background

b. Diagnostic Tests

0 Viral Isolation and Identification

0 Antibody Tests

c. Vaccines and Drugs

27. Epstein-Barr Virus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

28. Giardia Lamblia

a. Background

0 Life Cycle and Morphology

0 Morphology of Trophozoites

0 Clinical Disease

b. Diagnostic Tests

c. Vaccines and Drugs

29. Gonorrheaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs30. Granuloma Inguinalea. Backgroundb. Diagnostic Testsc. Vaccines and Drugs31. Hantavirusa. Background0 Identification of the Agent0 Transmission0 Other Rodent Hantaviruses0 Distribution0 Hantavirus Diseases0 Epidemiology0 Addendum in Proof-Northeastern Connection0 Previously Unknown Pathogens0 Cases Nationwideb. Diagnostic Tests0 An Immunohistochemistry Approach0 Hantavirus Rapid Diagnostic Test0 ELISA Diagnosis of Hantavirus PulmonarySyndrome0 IgG ELISA0 IgM Capture ELISAc. Vaccines and Drugs32. Helicobacter Pyloria. Background0 Pathogenesis0 Role in Peptic Ulcer Disease0 Role in Gastric Cancer0 Nonulcer Dyspepsiab. Diagnostic Testsc. Vaccines and Drugs0 Specific Therapeutic Regimens0 Who Should Be Treated?0 Participants in Controlled Clinical Trials

0 Patients with Refractory Peptic Ulcer

0 Patients with Refractory NUD

0 Patients in High-Risk Groups for Gastric

Cancer

33. Hepatitis

a. Background

b. Hepatitis A

c. Hepatitis B

d. Hepatitis C

0 Classification

0 Transmission of Infection

0 Occupational Hazards

0 Acute Hepatitis

0 Diagnosis of Acute Infection

0 Chronic Hepatitis

0 HCV and Other Chronic Liver Diseases

0 Alcoholic Liver Disease

0 Hepatitis B Coinfection

0 Cirrhosis and Hepatocellular Carcinoma

0 Diagnostic Tests

0 Possible Indications for HCV RNA Testing

0 Conclusions and Future Direction

e. Hepatitis D

0 Historical Perspective

0 Epidemiology

0 HBV-HDV "Coinfection" vs. "Superinfection"

0 Methods of Detecting HDV

0 Prevention

f. Hepatitis E

0 Background

0 Prevalence of the Disease

0 Diagnostic Tests

0 Epidemiologic Serosurveys

0 Serologic Cross-Reactivity

g. Hepatitis G

0 Vaccines and Drugs

34. Herpes Simplex Virus

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

35. Human Herpes Virus-6 (HHV-6)a. Background0 HIV-6 Infectionsb. Diagnostic Testsc. Vaccines and Drugs36. Influenza Virusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs37. Legionellaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs38. Lyme Diseasea. Background0 Clinical Description0 Clinical Case Definition0 Laboratory Criteria for Diagnosis0 Case Classificationb. Diagnostic Testsc. Vaccines and Drugs39. Lymphogranuloma Venereum (LGV)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs40. Malariaa. Backgroundb. Diagnostic Tests0 Potential Diagnositic Problems with PositivePatients from Non-endemic Areas- Patient- Laboratory- Physicianc. Vaccines and Drugs41. Measles (Rubeola)a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs

42. Meningitis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

0 Development of Polysaccharide Vaccines

0 Quadrivalent Vaccine Development

0 Meningococcal A.C.Y. & W-135 Vaccines

0 Efficacy of Group C Vaccine

0 Efficacy of Group A Vaccine

0 Combinations of Group A and C Vaccines

0 Group B Efficacy Trials

0 Future Direction

43. Microsporidium

a. Background

0 Prevalence and Geographic Distribution

0 Sources of Human Infection and Transmission

b. Diagnostic Tests

0 Light Microscopic Examination of Stool

Specimens By Chromotrope Staining

0 Stool Concentration Methods

0 Chemofluorescent Agents

0 Giemsa Staining of Stool Specimens

0 Cytologic Diagnosis

0 Histologic Examination

0 Electron Microscopy

0 Examination of Bodily Fluids

0 Examination of Tissue Sections

0 Immunofluorescence Detection Procedures

0 Serology

0 Cell Culture

0 Approach to Diagnosis

0 Evaluation of Patients with Presumptive

Intestinal Microsporidiosis

0 Evaluation of Patients with Presumptive

Ocular Microsporidiosis

c. Vaccines and Drugs

44. Mononucleosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

45. Mumpsa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs0 Efficacy of Vaccination0 Future Issues46. Mycoplasmaa. Background0 Ureaplasma Urealyticum & Mycoplasma Hominisb. Diagnostic Testsc. Vaccines and Drugs47. Papillomavirusesa. Background0 HPV in Cancer0 Cervical Neoplasmb. Diagnostic Testsc. Vaccines and Drugs0 Prevention48. Parvovirus B19a. Backgroundb. Diagnostic Testsc. Vaccines and Drugs49. Pneumoniaa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs50. Polyomavirusesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs51. Pseudomonas Aeruginosaa. Background0 Virulence Factorsb. Diagnostic Testsc. Vaccines and Drugs52. Rabiesa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs

53. Respiratory Syncytial Virus (RSV)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

54. RhinoViruses

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

55. RotaVirus (REOVIRUS)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

56. Rubella(MEASLES)

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

0 Developing Countries

0 Elimination and Eradication of Measles

0 New Developments

57. Salmonellosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

58. Septicemia

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

59. Shigellosis

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

60. Staphylococcus Aureus

a. Background

0 The Genus Taphylococcus

b. Diagnostic Tests

c. Vaccines and Drugs

0 Prevention

61. Streptococci

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs0 Group A Streptococci0 Group B Streptococci62. Syphilisa. Backgroundb. Diagnostic Tests0 Biopsy0 Rabbit Infectivity Testing0 Other Diagnostic Modalitiesc. Vaccines and Drugs0 Syphilis and HIV Infection0 Syphilis As a Cofactor for HIV Transmission0 Basic Science Issues63. Toxoplasmosisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs64. Trichomonas Vaginalisa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs65. Tuberculosisa. Backgroundb. Diagnostic Tests0 Microscopic Characteristics0 Cultural Characteristics0 Detection of Antibodies0 Skin Tests0 MDRTBc. Vaccines and Drugs66. Vibrioa. Backgroundb. Diagnostic Testsc. Vaccines and Drugs67. West Nile Virusa. Background- Clinical Syndromesb. Diagnostic Testsc. Vaccines and Drugs

68. Yersina

a. Background

b. Diagnostic Tests

c. Vaccines and Drugs

B. Instrumentation Review and Market Needs

0 Abbott AxSYM

0 Abbott IMx/IMx Select

0 Anagen AN2000/AuraFlex

0 Beckman Coulter Access

0 BioChem Pharma/SR1

0 BioMerieux/Vitek Vidas

0 Biotrol System 7000

0 Chiron ACS: Centaur

0 Chiron ACS: 180

0 J&J Diagnostics/Amersham Amerlite

0 J&J Diagnostics Vitros ECi

0 Olympus PK310

0 Roche Cobas Core

0 Roche Elecsys 1010/2010

0 Roche ES 22

0 Roche ES 33

0 Roche ES 300/300AL

0 Siemens ELISA Processor II/III

0 Siemens Immuno 1

0 Siemens/Opus/Plus/Magnum

0 Siemens Stratus

0 Tosoh AIA-1200/1200DX/NexIA/600

0 Wallac/Pharmacia Delfia

C. Emerging Diagnostic Technologies

1. DNA Probes

a. Technology Overview

b. Amplification Methods

0 Polymerase Chain Reaction

- Robotics

- Temperature Cyclers

- PCR Variations

0 Immuno-PCR

0 QC-PCR

0 DAP-PCR

0 Ligase Chain Reaction0 Branched DNA0 Q-Beta Replicase0 Nucleic-Acid Sequence-Based0 Strand Displacement Activation0 Self-Sustained Sequence Replicase2. Monoclonal Antibodies3. Immunoassaysa. Technological Principleb. Enzyme Immunoassays (EIA)0 Overview0 ELISA0 Dot Immunobinding Assays0 Capillary Immunoassays0 Particle-Membrane CaptureImmunoassays0 Enzyme Amplificationc. Fluorescent Immunoassays0 Fluorescence Polarization0 Time-Resolved Pulse Fluorescenced. Luminescence0 Chemiluminescence0 Bioluminescencee. Latex Agglutinationf. Immunoprecipitation4. Differential Light Scattering5. Microcomputers and Automation6. Artificial Intelligence7. Liposomes8. Flow Cytometry9. Chromatography10. MRI11. Gel Microdroplets12. OtherD. Personal TestingE. Worldwide Business EnvironmentF. Worldwide Market StructureG. Worldwide Market Size and Growth

U.K.

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth and Major Suppliers

Major Product Development Opportunities

A. Instrumentation

B. Reagent Kits and Test Systems/Panels

C. Computers, Software and Automation

D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies for Decentralized

Testing Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types of Distributors

7. Market Segmentation

Potential Market Entry Barriers and Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge and Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

Competitive Assessments- Abbott- Affymetrix- Beckman Coulter- Becton Dickinson- bioMerieux- Bio-Rad- Cepheid- Diamedix- DiaSorin- Eiken Chemical- Enzo Biochem- Fujirebio- Gen-Probe- Hologic- ID Biomedical- J&J Diagnostics- Kreatech- Life Technology- Lonza- Nanogen- Novartis Diagnostics- Qiagen- Roche- Scienion- Sequenom- SeraCare- Siemens- Takara Bio- Thermo Fisher- Wallac- Wako

List of Tables

Major Companies Developing or Marketing AIDS Tests

Major Companies Developing or Marketing Adenovirus

Tests

Major Companies Developing or Marketing Bartonella

Tests

Major Companies Developing or Marketing

Campylobacter Tests

Major Companies Developing or Marketing Candida

Tests

Major Companies Developing or Marketing Chlamydia

Tests

Major Companies Developing or Marketing Clostridium

Tests

Major Companies Developing or Marketing Coronavirus

Tests

Major Companies Developing or Marketing Cryptosporidium

Tests

Major Companies Developing or Marketing CMV Tests

Major Companies Developing or Marketing Echovirus

Tests

Major Companies Developing or Marketing Enterovirus

Tests

Major Companies Developing or Marketing EBV Tests

Major Companies Developing or Marketing GiardiaTestsMajor Companies Developing or Marketing GonorrheaTestsMajor Companies Developing or Marketing HantavirusTestsMajor Companies Developing or Marketing HelicobacterPylori TestsMajor Companies Developing or Marketing HepatitisTestsMajor Companies Developing or Marketing HerpesTestsMajor Companies Developing or Marketing InfluenzaTestsMajor Companies Developing or Marketing LegionellaTestsMajor Companies Developing or Marketing Lyme DiseaseTestsMajor Companies Developing or Marketing LymphogranulomaTestsMajor Companies Developing or Marketing MalariaTestsMajor Companies Developing or Marketing MeaslesTestsMajor Companies Developing or Marketing MeningitisTests

Major Companies Developing or Marketing Microsporidium

Tests

Major Companies Developing or Marketing

Mononucleosis Tests

Major Companies Developing or Marketing Mumps Tests

Major Companies Developing or Marketing Mycoplasma

Tests

Major Companies Developing or Marketing Papilloma

Virus Tests

Major Companies Developing or Marketing Parvovirus

Tests

Major Companies Developing or Marketing Pneumonia

Tests

Major Companies Developing or Marketing RSV Tests

Major Companies Developing or Marketing Rotavirus

Tests

Major Companies Developing or Marketing Rubella

Tests

Major Companies Developing or Marketing Salmonella

Tests

Major Companies Developing or Marketing Septicemia

Tests

Major Companies Developing or Marketing Shigella

Tests

Major Companies Developing or Marketing Staphylococci

Tests

Major Companies Developing or MarketingStreptococci TestsMajor Companies Developing or Marketing SyphilisTestsMajor Companies Developing or Marketing ToxoplasmosisTestsMajor Companies Developing or Marketing TrichomonasTestsMajor Companies Developing or Marketing TuberculosisTestsMajor Companies Developing or Marketing West NileTestsMajor Companies Developing or Marketing Yersinia TestsWorldwide All Market Segments LaboratoriesPerforming Microbiology Tests by CountryWorldwide All Market Segments Total Microbiology TestVolume Forecast by CountryWorldwide All Market Segments Total MicrobiologyDiagnostics Market Forecast by CountryInfectious Disease Tests Major Issues and MarketPotential For Personal TestingU.K. Summary TableAll Infectious Diseases Test Volume and DiagnosticsSales Forecast by Market SegmentU.K.Laboratories Performing Infectious Disease Testsby Market Segment

U.K.

Hospital Laboratories Performing Infectious Disease

Tests by Bed Size

U.K.

Commercial/Private Laboratories Performing Infectious

Disease Tests by Annual Test Volume

U.K.

All Market Segments Infectious Disease Test Volume Forecast

U.K.

Hospital Laboratories Infectious Disease Test Volume Forecast

U.K.

Blood Banks Infectious Disease Test Volume Forecast

U.K.

Public Health Laboratories Infectious Disease Test

Volume Forecast

U.K.

Commercial/Private Laboratories Infectious Disease

Test Volume Forecast

U.K.

All Market Segments Infectious Disease Diagnostics

Market Forecast

U.K.

Hospital Laboratories Infectious Disease Diagnostics

Market Forecast

U.K.

Blood Banks Infectious Disease Diagnostics Market Forecast

U.K.

Public Health Laboratories Infectious Disease

Diagnostics Market Forecast

U.K.Commercial/Private Laboratories Infectious DiseaseDiagnostics Market ForecastU.K.HIV or HIVI/HIVII Test Volume and Diagnostics SalesForecast by Market SegmentU.K.HTLV I or HTLV I/HTLV II Test Volume and DiagnosticsSales Forecast by Market SegmentU.K.HIVAg Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.Western Blot/Other Confirmatory Test Volume andDiagnostics Sales Forecast by Market SegmentU.K.AdenovirusTest Volume and Diagnostics Sales Forecast by Market SegmentU.K.AeromonadsTest Volume and Diagnostics Sales Forecast by Market SegmentU.K.BEATest Volume and Diagnostics Sales Forecast by Market Segment

U.K.

Blastocystis Hominis Test Volume and Diagnostics Sales

Forecast by Market Segment

U.K.

Campylobacter

Test Volume and Diagnostics Sales Forecast by Market Segment

U.K.

Candida

Test Volume and Diagnostics Sales Forecast by Market Segment

U.K.

Chancroid

Test Volume and Diagnostics Sales Forecast by Market Segment

U.K.

Chlamydia Test Volume and Diagnostics Sales Forecast by Market

Segment

U.K.

Clostridium Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Coronavirus Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

CoxsackieVirus Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Cryptosporidium Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Cyclospora Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.CMV Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.E. Coli Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.Echovirus Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.Encephalitis Test Volume and Diagnostics Sales Forecast byMarket SegmentU.K.Enterovirus Test Volume and Diagnostics Sales Forecast byMarketSegmentU.K.EBV Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.Giardia Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.Gonorrhea Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.Granuloma Inguinale Test Volume and Diagnostics SalesForecast by Market SegmentU.K.Helicobacter Pylori Test Volume and Diagnostics SalesForecast by Market Segment

U.K.

HAV NAT Test Volume and Diagnostics Sales Forecast by Market

Segment

U.K.

HBV NAT Test Volume and Diagnostics Sales Forecast by Market

Segment

U.K.

HbsAg Test Volume and Diagnostics Sales Forecast by Market

Segment

U.K.

Hepatitis C Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Anti-HBc Test Volume and Diagnostics Sales Forecast by Market

Segment

U.K.

Anti-HBs Test Volume and Diagnostics Sales Forecast by Market

Segment

U.K.

Anti-HAV Test Volume and Diagnostics Sales Forecast by Market

Segment

U.K.

Hepatitis Delta Test Volume and Diagnostics Sales

Forecast by Market Segment

U.K.

HBcAg Test Volume and Diagnostics Sales Forecast by Market

Segment

U.K.HBeAg Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.Herpes Simplex I and II Test Volume and DiagnosticsSales Forecast by Market SegmentU.K.Herpes Type VI Test Volume and DiagnosticsSales Forecast by Market SegmentU.K.HTLV-I/II Test Volume and DiagnosticsSales Forecast by Market SegmentU.K.Influenza Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.Legionella Test Volume and Diagnostics Sales Forecast byMarket SegmentU.K.Lyme Disease Test Volume and Diagnostics Sales Forecast byMarket SegmentU.K.Lymphogranuloma Test Volume and Diagnostics Sales Forecast byMarket SegmentU.K.Malaria Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.Measles Test Volume and Diagnostics Sales Forecast by MarketSegment

U.K.

Meningitis Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Microsporidium Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Mononucleosis Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Mumps Test Volume and Diagnostics Sales Forecast by Market

Segment

U.K.

Mycoplasma Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Papilloma Virus Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Parvovirus Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Pneumonia Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Polyomaviruses Test Volume and Diagnostics Sales

Forecast by Market Segment

U.K.

Pseudomonas Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.Rabies Test Volume and Diagnostics Sales Forecast byMarket SegmentU.K.RSV Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.Rhinovirus Test Volume and Diagnostics Sales Forecast byMarket SegmentU.K.Rotavirus Test Volume and Diagnostics Sales Forecast byMarket SegmentU.K.Rubella Test Volume and Diagnostics Sales Forecast by MarketSegmentU.K.Salmonella Test Volume and Diagnostics Sales Forecast byMarket SegmentU.K.Septicemia Test Volume and Diagnostics Sales Forecast byMarket SegmentU.K.Shigella Test Volume and Diagnostics Sales Forecast byMarket SegmentU.K.Staphylococci Test Volume and Diagnostics Sales Forecast byMarket SegmentU.K.Streptococci Test Volume and Diagnostics Sales Forecast byMarket Segment

U.K.

Syphilis Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Toxoplasmosis Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Trichomonas Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Tuberculosis Test Volume and Diagnostics Sales Forecast by

Market Segment

U.K.

Vibrio Test Volume and Diagnostics Sales Forecast

by Market Segment

U.K.

West Nile Test Volume and Diagnostics Sales Forecast

by Market Segment

U.K.

Yersinia Test Volume and Diagnostics Sales Forecast

by Market Segment

U.K.

AIDS Testing Market Diagnostics Sales by Major

Supplier

U.K.

Campylobacter Testing Market Diagnostics Sales by

Major Supplier

U.K.Candida Testing Market Diagnostics Sales by MajorSupplierU.K.Gonorrhea Testing Market Diagnostics Sales byMajor SupplierU.K.Hepatitis Testing Market Diagnostics Sales by MajorSupplierU.K.Hepatitis C Testing Market Diagnostics Sales byMajor SupplierU.K.Influenza Testing Market Diagnostics Sales byMajor SupplierU.K.Mycoplasma Testing Market Diagnostics Sales byMajor SupplierU.K.Pneumonia Testing Market Diagnostics Sales by MajorSupplierU.K.RSV Testing Market Diagnostics Sales by Major SupplierU.K.Rubella Testing Market Diagnostics Sales by MajorSupplierU.K.Septicemia Testing Market Diagnostics Sales by MajorSupplier

U.K.

Shigella Testing Market Diagnostics Sales by Major

Supplier

U.K.

Streptococci Testing Market Diagnostics Sales by

Major Supplier

U.K.

Syphilis Testing Market Diagnostics Sales by Major

Supplier

U.K.

Tuberculosis Testing Market Diagnostics Sales by

Major Supplier

U.K.

Infectious Disease Diagnostic Testing Instrumentation

Major Systems Estimated Placements and Installed Base

To order this report:In Vitro Diagnostic Industry: Future UK Microbiology Testing Market Outlook

More  

Market Research Report

Check our  

Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

Visit link:
Future UK Microbiology Testing Market Outlook